Literature DB >> 9547266

The activation function 2 domain of hepatic nuclear factor 4 is regulated by a short C-terminal proline-rich repressor domain.

V P Iyemere1, N H Davies, G G Brownlee.   

Abstract

Hepatic nuclear factor 4 (HNF4) is a transcription factor whose expression is crucial for mouse embryonic development, for liver-specific gene expression and for the prevention of one form of maturity-onset diabetes of the young. Its domain structure has been defined previously and is similar to other members of the nuclear receptor superfamily. A repressor domain has now been localised to a region of 14 amino acids (residues 428-441) near the C-terminus of HNF4 and is sufficient by itself to repress the activity of the activation function 2 (AF2) domain. Multiple mutations within this repressor domain enhance activity. Interestingly, this repressor domain shares homology with a repressor domain in the progesterone receptor. In a detailed mutagenesis study of the AF2 core, we demonstrate that L 366, which is conserved in the AF2 core between HNF4 and a number of orphan nuclear receptors, is essential for the full activity of the AF2 domain. Furthermore, a double mutation of E 363 and L 366 suggests that these residues might act in a cooperative manner.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9547266      PMCID: PMC147528          DOI: 10.1093/nar/26.9.2098

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  19 in total

1.  TFIIB-directed transcriptional activation by the orphan nuclear receptor hepatocyte nuclear factor 4.

Authors:  S Malik; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Authors:  J P Renaud; N Rochel; M Ruff; V Vivat; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

3.  The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor.

Authors:  J Xu; Z Nawaz; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

Review 4.  Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?

Authors:  P Kastner; M Mark; P Chambon
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

5.  Further evidence for the importance of an androgen response element in the factor IX promoter.

Authors:  G E Morgan; G Rowley; P M Green; M Chisholm; F Giannelli; G G Brownlee
Journal:  Br J Haematol       Date:  1997-07       Impact factor: 6.998

6.  Differential in vivo activation of the class II and class III snRNA genes by the POU-specific domain of Oct-1.

Authors:  S Murphy
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

7.  Functional domains of the nuclear receptor hepatocyte nuclear factor 4.

Authors:  M Hadzopoulou-Cladaras; E Kistanova; C Evagelopoulou; S Zeng; C Cladaras; J A Ladias
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

8.  HNF4beta, a new gene of the HNF4 family with distinct activation and expression profiles in oogenesis and embryogenesis of Xenopus laevis.

Authors:  B Holewa; D Zapp; T Drewes; S Senkel; G U Ryffel
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

9.  Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)

Authors:  K Yamagata; H Furuta; N Oda; P J Kaisaki; S Menzel; N J Cox; S S Fajans; S Signorini; M Stoffel; G I Bell
Journal:  Nature       Date:  1996-12-05       Impact factor: 49.962

10.  Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes.

Authors:  T Drewes; S Senkel; B Holewa; G U Ryffel
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

View more
  11 in total

1.  Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1.

Authors:  F M Sladek; M D Ruse; L Nepomuceno; S M Huang; M R Stallcup
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  The activity of the activation function 2 of the human hepatocyte nuclear factor 4 (HNF-4alpha) is differently modulated by F domains from various origins.

Authors:  L Suaud; P Formstecher; B Laine
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Characterization of novel peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) isoform in human liver.

Authors:  Thomas K Felder; Selma M Soyal; Hannes Oberkofler; Penelope Hahne; Simon Auer; Richard Weiss; Gabriele Gadermaier; Karl Miller; Franz Krempler; Harald Esterbauer; Wolfgang Patsch
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

4.  Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4alpha1: modulation by the F domain.

Authors:  Michael D Ruse; Martin L Privalsky; Frances M Sladek
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

5.  Hepatocyte nuclear factor 4alpha enhances the hepatocyte nuclear factor 1alpha-mediated activation of transcription.

Authors:  J Eeckhoute; P Formstecher; B Laine
Journal:  Nucleic Acids Res       Date:  2004-05-11       Impact factor: 16.971

6.  Identification of novel co-repressor molecules for Interferon Regulatory Factor-2.

Authors:  Kay S Childs; Stephen Goodbourn
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

7.  Induction of Hepatic Metabolic Functions by a Novel Variant of Hepatocyte Nuclear Factor 4γ.

Authors:  Shota Sasaki; Mizuho Urabe; Tsukasa Maeda; Junko Suzuki; Ryota Irie; Masanori Suzuki; Yasuhiro Tomaru; Masakiyo Sakaguchi; Frank J Gonzalez; Yusuke Inoue
Journal:  Mol Cell Biol       Date:  2018-11-28       Impact factor: 4.272

8.  SUMOylation of HNF4α regulates protein stability and hepatocyte function.

Authors:  Wenli Zhou; Zara Hannoun; Ellis Jaffray; Claire N Medine; James R Black; Sebastian Greenhough; Liang Zhu; James A Ross; Stuart Forbes; Ian Wilmut; John P Iredale; Ronald T Hay; David C Hay
Journal:  J Cell Sci       Date:  2012-04-14       Impact factor: 5.285

Review 9.  Biological influence of Hakai in cancer: a 10-year review.

Authors:  Luis A Aparicio; Manuel Valladares; Moisés Blanco; Guillermo Alonso; Angélica Figueroa
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

Review 10.  Therapeutic Potential of HNF4α in End-stage Liver Disease.

Authors:  Ricardo Diaz-Aragon; Michael C Coard; Sriram Amirneni; Lanuza Faccioli; Nils Haep; Michelle R Malizio; Takashi Motomura; Zehra N Kocas-Kilicarslan; Alina Ostrowska; Rodrigo M Florentino; Carla Frau
Journal:  Organogenesis       Date:  2021-10-02       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.